• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成化学:用深度学习生成模型进行药物发现。

Generative chemistry: drug discovery with deep learning generative models.

机构信息

Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

NIH National Center of Excellence for Computational Drug Abuse Research, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

出版信息

J Mol Model. 2021 Feb 4;27(3):71. doi: 10.1007/s00894-021-04674-8.

DOI:10.1007/s00894-021-04674-8
PMID:33543405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10984615/
Abstract

The de novo design of molecular structures using deep learning generative models introduces an encouraging solution to drug discovery in the face of the continuously increased cost of new drug development. From the generation of original texts, images, and videos, to the scratching of novel molecular structures the creativity of deep learning generative models exhibits the height machine intelligence can achieve. The purpose of this paper is to review the latest advances in generative chemistry which relies on generative modeling to expedite the drug discovery process. This review starts with a brief history of artificial intelligence in drug discovery to outline this emerging paradigm. Commonly used chemical databases, molecular representations, and tools in cheminformatics and machine learning are covered as the infrastructure for generative chemistry. The detailed discussions on utilizing cutting-edge generative architectures, including recurrent neural network, variational autoencoder, adversarial autoencoder, and generative adversarial network for compound generation are focused. Challenges and future perspectives follow.

摘要

使用深度学习生成模型对分子结构进行从头设计,为药物发现带来了令人鼓舞的解决方案,有助于应对新药研发成本的不断增加。从原始文本、图像和视频的生成,到新颖分子结构的生成,深度学习生成模型的创造力展示了机器智能所能达到的高度。本文旨在综述基于生成模型来加速药物发现过程的生成化学的最新进展。本文从人工智能在药物发现领域的简要历史开始,概述了这一新兴范例。涵盖了化学信息学和机器学习中常用的化学数据库、分子表示和工具,作为生成化学的基础。详细讨论了如何利用先进的生成架构,包括递归神经网络、变分自动编码器、对抗自动编码器和生成对抗网络进行化合物生成。随后探讨了挑战和未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/e37cb81ce757/nihms-1881878-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/7727276498a4/nihms-1881878-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/8ba6ea938de0/nihms-1881878-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/c1d94cf1c8b3/nihms-1881878-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/0a359f6a437c/nihms-1881878-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/e37cb81ce757/nihms-1881878-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/7727276498a4/nihms-1881878-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/8ba6ea938de0/nihms-1881878-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/c1d94cf1c8b3/nihms-1881878-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/0a359f6a437c/nihms-1881878-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0b/10984615/e37cb81ce757/nihms-1881878-f0005.jpg

相似文献

1
Generative chemistry: drug discovery with deep learning generative models.生成化学:用深度学习生成模型进行药物发现。
J Mol Model. 2021 Feb 4;27(3):71. doi: 10.1007/s00894-021-04674-8.
2
druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.druGAN:一种高级生成对抗自动编码器模型,可在计算机上从头生成具有所需分子特性的新分子。
Mol Pharm. 2017 Sep 5;14(9):3098-3104. doi: 10.1021/acs.molpharmaceut.7b00346. Epub 2017 Aug 4.
3
Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.利用机器学习进展进行药物发现和分子生物学中的数据整合
Methods Mol Biol. 2021;2190:167-184. doi: 10.1007/978-1-0716-0826-5_7.
4
Navigating the frontier of drug-like chemical space with cutting-edge generative AI models.利用最先进的生成式人工智能模型探索类药性化学空间的前沿。
Drug Discov Today. 2024 Sep;29(9):104133. doi: 10.1016/j.drudis.2024.104133. Epub 2024 Aug 3.
5
De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.使用生成对抗网络的从头肽和蛋白质设计:最新进展
J Chem Inf Model. 2022 Feb 28;62(4):761-774. doi: 10.1021/acs.jcim.1c01361. Epub 2022 Feb 7.
6
The power of deep learning to ligand-based novel drug discovery.深度学习在基于配体的新药发现中的作用。
Expert Opin Drug Discov. 2020 Jul;15(7):755-764. doi: 10.1080/17460441.2020.1745183. Epub 2020 Mar 31.
7
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.人工智能到深度学习:药物发现的机器智能方法。
Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12.
8
Generative machine learning for de novo drug discovery: A systematic review.生成式机器学习在从头药物发现中的应用:系统评价。
Comput Biol Med. 2022 Jun;145:105403. doi: 10.1016/j.compbiomed.2022.105403. Epub 2022 Mar 13.
9
Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular Design, Dimensionality Reduction, and Peptide and Protein Design.生成对抗网络在药物设计和发现中的相关应用:分子设计、降维和肽与蛋白质设计。
Molecules. 2020 Jul 16;25(14):3250. doi: 10.3390/molecules25143250.
10
Generative Deep Learning for Targeted Compound Design.生成式深度学习在靶向化合物设计中的应用。
J Chem Inf Model. 2021 Nov 22;61(11):5343-5361. doi: 10.1021/acs.jcim.0c01496. Epub 2021 Oct 26.

引用本文的文献

1
Optimizing drug design by merging generative AI with a physics-based active learning framework.通过将生成式人工智能与基于物理学的主动学习框架相结合来优化药物设计。
Commun Chem. 2025 Aug 8;8(1):238. doi: 10.1038/s42004-025-01635-7.
2
Generative artificial intelligence based models optimization towards molecule design enhancement.基于生成式人工智能的模型优化以增强分子设计
J Cheminform. 2025 Aug 4;17(1):116. doi: 10.1186/s13321-025-01059-4.
3
Neural Networks for Predicting and Classifying Antimicrobial Resistance Sequences in Porphyromonas gingivalis.

本文引用的文献

1
Advances and Perspectives in Applying Deep Learning for Drug Design and Discovery.深度学习在药物设计与发现中的应用进展与展望
Front Robot AI. 2019 Nov 5;6:108. doi: 10.3389/frobt.2019.00108. eCollection 2019.
2
Mol-CycleGAN: a generative model for molecular optimization.Mol-CycleGAN:一种用于分子优化的生成模型。
J Cheminform. 2020 Jan 8;12(1):2. doi: 10.1186/s13321-019-0404-1.
3
A de novo molecular generation method using latent vector based generative adversarial network.一种使用基于潜在向量的生成对抗网络的从头分子生成方法。
用于预测和分类牙龈卟啉单胞菌抗微生物耐药性序列的神经网络
Int Dent J. 2025 Jul 5;75(5):100890. doi: 10.1016/j.identj.2025.100890.
4
AI-Based Drug Discovery and Design for Different Genetic Designs.基于人工智能的针对不同基因设计的药物发现与设计
Methods Mol Biol. 2025;2952:125-148. doi: 10.1007/978-1-0716-4690-8_8.
5
Capsule neural network and its applications in drug discovery.胶囊神经网络及其在药物发现中的应用。
iScience. 2025 Mar 14;28(4):112217. doi: 10.1016/j.isci.2025.112217. eCollection 2025 Apr 18.
6
A beginner's approach to deep learning applied to VS and MD techniques.深度学习应用于VS和MD技术的初学者方法。
J Cheminform. 2025 Apr 8;17(1):47. doi: 10.1186/s13321-025-00985-7.
7
BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data.2024年的BindingDB:蛋白质-小分子结合数据的可 FAIR 化知识库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D1633-D1644. doi: 10.1093/nar/gkae1075.
8
Hybrid deep learning technique for COX-2 inhibition bioactivity detection against breast cancer disease.用于检测针对乳腺癌疾病的COX-2抑制生物活性的混合深度学习技术
Biomed Eng Lett. 2024 Apr 10;14(4):631-647. doi: 10.1007/s13534-024-00355-6. eCollection 2024 Jul.
9
Navigating the complexity of p53-DNA binding: implications for cancer therapy.解析p53与DNA结合的复杂性:对癌症治疗的启示
Biophys Rev. 2024 Jul 11;16(4):479-496. doi: 10.1007/s12551-024-01207-4. eCollection 2024 Aug.
10
Introducing 'identification probability' for automated and transferable assessment of metabolite identification confidence in metabolomics and related studies.引入“识别概率”用于代谢组学及相关研究中代谢物识别可信度的自动化和可转移评估。
bioRxiv. 2024 Jul 31:2024.07.30.605945. doi: 10.1101/2024.07.30.605945.
J Cheminform. 2019 Dec 3;11(1):74. doi: 10.1186/s13321-019-0397-9.
4
High-Throughput Screening: today's biochemical and cell-based approaches.高通量筛选:今天的生化和基于细胞的方法。
Drug Discov Today. 2020 Oct;25(10):1807-1821. doi: 10.1016/j.drudis.2020.07.024. Epub 2020 Aug 12.
5
Pain-CKB, A Pain-Domain-Specific Chemogenomics Knowledgebase for Target Identification and Systems Pharmacology Research.疼痛化学基因组学知识库(Pain-CKB),用于目标识别和系统药理学研究的疼痛领域特异性化学基因组学知识库。
J Chem Inf Model. 2020 Oct 26;60(10):4429-4435. doi: 10.1021/acs.jcim.0c00633. Epub 2020 Sep 2.
6
Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research.病毒-CKB:COVID-19 研究的综合生物信息学平台和分析资源。
Brief Bioinform. 2021 Mar 22;22(2):882-895. doi: 10.1093/bib/bbaa155.
7
Advances in G protein-coupled receptor high-throughput screening.G 蛋白偶联受体高通量筛选技术的进展。
Curr Opin Biotechnol. 2020 Aug;64:210-217. doi: 10.1016/j.copbio.2020.06.004. Epub 2020 Jul 10.
8
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).比较用于预测药物性肝损伤(DILI)的机器学习算法。
Mol Pharm. 2020 Jul 6;17(7):2628-2637. doi: 10.1021/acs.molpharmaceut.0c00326. Epub 2020 Jun 8.
9
Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders.使用对抗自编码器实现所需转录组变化的分子生成
Front Pharmacol. 2020 Apr 17;11:269. doi: 10.3389/fphar.2020.00269. eCollection 2020.
10
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation.发现具有口服生物利用度的色酮衍生物作为强效和选择性 BRD4 抑制剂:骨架跃迁、优化和药理学评价。
J Med Chem. 2020 May 28;63(10):5242-5256. doi: 10.1021/acs.jmedchem.0c00035. Epub 2020 Apr 22.